Asensus Surgical, Inc.
ASXC · AMEX
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 21% | -13.9% | 159.3% | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -53.4% | -53.4% | -34.8% | -62.7% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -867.4% | -907.1% | -580.1% | -1,483.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -914.5% | -1,066.2% | -758.8% | -1,868.1% |
| EPS Diluted | -0.31 | -0.32 | -0.28 | -0.85 |
| % Growth | 3.1% | -14.3% | 67.1% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |